Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Companexia provides businesses with the tools to research, validate, and analyze companies by utilizing data from official public registries. This platform consolidates essential company information into a single interface, encompassing aspects such as legal status, registration information, details about directors and officers, ownership structures, financial data, filing histories, and associated entities. Tailored for compliance teams, legal experts, due diligence analysts, investors, and B2B teams, it enables users to evaluate companies swiftly and confidently. Rather than manually navigating through various registries, users can conduct a search for a company and access all crucial details within a streamlined process. Common applications of Companexia include conducting thorough company due diligence, performing Know Your Business (KYB) checks, investigating ownership structures, carrying out financial assessments, assessing risks, and undertaking general company verification, making it an invaluable resource for informed decision-making. Additionally, the ease of access to comprehensive data significantly enhances the efficiency of the verification process for its users.

Description

EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.

API Access

Has API No 

API Access

Has API Yes 

Screenshots View All

No images available

Screenshots View All

No images available

Integrations

No details available.

Integrations

No details available.

Pricing Details

Free
Free Trial No 
Free Version Yes 

Pricing Details

$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial Yes 
Free Version Yes 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App Yes 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) No 
In Person No 

Types of Training

Training Docs No 
Webinars No 
Live Training (Online) No 
In Person No 

Vendor Details

Company Name

Companexia

Founded

2026

Country

United States

Website

companexia.com/en

Vendor Details

Company Name

EquiReason

Founded

2026

Country

Turkey

Website

equireason.com

Product Features

Product Features

Alternatives

Alternatives

Dion Insight Reviews

Dion Insight

Dion Global Solutions
Clarion Reviews

Clarion

Wolters Kluwer Legal & Regulatory US